Viewing StudyNCT06429800



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06429800
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-28
First Post: 2024-05-21

Brief Title: A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants with Systemic Lupus Erythematosus
Sponsor: Atara Biotherapeutics
Organization: Atara Biotherapeutics

Conditions & Keywords Data

Conditions:
Name
Systemic Lupus Erythematosus
Lupus Nephritis
Keywords:
Name View
Epstein-Barr virus EBV T cells View
Lupus Nephritis LN View
Systemic Lupus Erythematosus SLE View
Anti CD19 Chimeric Antigen Receptor T cell CAR T Therapy View
Human leukocyte antigen HLA View